Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
March 8, 2026
Correction: The biosynthesis of N-acyalated tryptazolone in Mycobacterium tuberculosis and related bacteria
Julia Kleetz, Jason C Grigg, Adam A Hassan, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2022
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance
Stella Cellier-Goetghebeur, Kiana Lafontaine, Claudèle Lemay-St-Denis, et al.
Cancers
|
November 9, 2013
The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
Laura K Green, Mathew A Storey, Elsie M Williams, et al.
Water Research
|
November 18, 2005
Characterization of nitrogen-fixing cyanobacteria in the Brazilian Amazon floodplain
Marli de Fátima Fiore, Brett A Neilan, Janine N Copp, et al.
Molecular Biology and Evolution
|
September 19, 2025
From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance
Claudèle Lemay-St-Denis, Stella Cellier-Goetghebeur, Maxime St-Aubin, et al.
Cell Chemical Biology
|
March 7, 2017
Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene Therapy
Janine N Copp, Alexandra M Mowday, Elsie M Williams, et al.
The Biochemical Journal
|
October 4, 2015
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
Elsie M Williams, Rory F Little, Alexandra M Mowday, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications
Amir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, et al.
Elife
|
November 13, 2020
Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues
Kelsi R Hall, Katherine J Robins, Elsie M Williams, et al.
Biochemistry
|
August 13, 2019
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy
Elsie M Williams, Michelle H Rich, Alexandra M Mowday, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
March 8, 2026
Correction: The biosynthesis of N-acyalated tryptazolone in Mycobacterium tuberculosis and related bacteria
Julia Kleetz, Jason C Grigg, Adam A Hassan, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2022
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance
Stella Cellier-Goetghebeur, Kiana Lafontaine, Claudèle Lemay-St-Denis, et al.
Cancers
|
November 9, 2013
The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
Laura K Green, Mathew A Storey, Elsie M Williams, et al.
Water Research
|
November 18, 2005
Characterization of nitrogen-fixing cyanobacteria in the Brazilian Amazon floodplain
Marli de Fátima Fiore, Brett A Neilan, Janine N Copp, et al.
Molecular Biology and Evolution
|
September 19, 2025
From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance
Claudèle Lemay-St-Denis, Stella Cellier-Goetghebeur, Maxime St-Aubin, et al.
Cell Chemical Biology
|
March 7, 2017
Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene Therapy
Janine N Copp, Alexandra M Mowday, Elsie M Williams, et al.
The Biochemical Journal
|
October 4, 2015
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
Elsie M Williams, Rory F Little, Alexandra M Mowday, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications
Amir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, et al.
Elife
|
November 13, 2020
Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues
Kelsi R Hall, Katherine J Robins, Elsie M Williams, et al.
Biochemistry
|
August 13, 2019
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy
Elsie M Williams, Michelle H Rich, Alexandra M Mowday, et al.
Page
of 3